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The Relationship Between Restless Legs
Syndrome and Neuropathy
We commend Gemignani and colleagues for important obser-
vations1 on the prevalence of Restless Legs Syndrome (RLS) in
104 patients with symptoms of exclusive small fiber neuropa-
thy, peripheral neuropathy, or mononeuropathy multiplex. The
co-occurrence of neuropathy and RLS has been studied from
two standpoints in the past, without reaching a consensus: the
frequency of neuropathy in RLS patients, and the frequency of
RLS in neuropathy patients. The estimated frequency of one
condition when the other is present has varied between 5%2 and
45%,3 due in part to the use of restrictive definitions, inclusion
of only certain subtypes of neuropathy, excessively stringent
electrodiagnostic criteria, or examination of a sample of RLS
patients, who tend to be younger than the average neuropathy
population, and perhaps less likely to have neuropathy. If the
frequency of RLS in neuropathy patients is, at the very least,
higher than the estimated population prevalence of 10%,4 the
identification and treatment of RLS may represent an often
overlooked opportunity to improve the quality of life in patients
with peripheral neuropathy.
The data presented by Gemignani et al. suggest that the
prevalence of RLS is about 3 times higher in the setting of
peripheral neuropathy than in the general population. The au-
thors excluded patients whose RLS was the only manifestation
of neuropathy when the onset occurred before age 50 or if there
was no associated disease to explain the peripheral neuropathy.
The age limit is somewhat arbitrary; the authors themselves
have previously reported increased prevalence of RLS in
younger patients with hereditary motor and sensory neuropa-
thy.5 The population of patients with Type 2 diabetes (and
consequently, neuropathy) in the United States is growing
younger, and two previous studies have reported a higher
prevalence of RLS than that reported in the general population
among these patients, up to 24%6 and 27%.7 Excluding idio-
pathic peripheral neuropathy patients with RLS may also result
in underestimating the prevalence of both conditions. The au-
thors also excluded those with a family history of RLS, despite
a previous study showing that up to 13% of patients with both
peripheral neuropathy and RLS will have a positive family
history.8 Therefore, we suspect that Gemignani et al. would not
have found substantially lower frequencies of RLS had they
studied all peripheral neuropathy patients without restriction.
As the authors noted, they could not have used the recently
revised criteria for RLS9 at the time they conducted their study.
The most significant change from the original criteria10 involves
substitution of the concept of relief with movement for “motor
restlessness,” a term that often caused confusion. However, given
that the authors conducted a formal clinical interview to assess
whether patients met the necessary criteria, we do not believe
much information was lost using the older criteria for RLS.
Overall, we concur with the authors’ conclusion that the prev-
alence of RLS is increased in patients with peripheral neuropathy,
and this raises interesting questions about pathophysiology. The
study unfortunately restricted laboratory investigation to values of
hemoglobin and mean corpuscular volume, to assess for anemia.
Iron is an essential co-factor for tyrosine hydroxylase, the rate-
limiting enzyme involved in the synthesis of dopamine, and cur-
rently, RLS is viewed as a consequence of central dopaminergic
dysfunction. Given repeated observations that when RLS and
neuropathy coexist, the neuropathy tends to involve axon loss
rather than myelin, further research is needed to study the role of
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